Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 12, 2008 - Issue 8
Submit an article Journal homepage
78
Views
10
CrossRef citations to date
0
Altmetric
Review

DNA methylation: A promising target for the twenty-first century

Paula A Abreu Federal Fluminense University, Biology Institute, Department of Celular and Molecular Biology, CEP 24020-150 Niterói, Rio de Janeiro, Brazil +55 21 26292294; +55 21 26292284; [email protected]; Federal Fluminense University, Biology Institute, Neuroimmunology Postgraduate course, CEP 24020-150 Niterói, Rio de Janeiro, Brazil
,
Gisela Dellamora-Ortiz Federal University of Rio de Janeiro, Faculty of Pharmacy, CEP 21941-590, Rio de Janeiro, RJ, Brazil
,
Luiz R Leão-Ferreira Federal Fluminense University, Biology Institute, Department of Celular and Molecular Biology, CEP 24020-150 Niterói, Rio de Janeiro, Brazil +55 21 26292294; +55 21 26292284; [email protected]
,
Maria Gouveia Federal Fluminense University, Biology Institute, Neuroimmunology Postgraduate course, CEP 24020-150 Niterói, Rio de Janeiro, Brazil
,
Esteban Braggio National Institute of Cancer, Marrow Bone Transplant Center, CEP 21941-590, Rio de Janeiro, RJ, Brazil
,
Ilana Zalcberg National Institute of Cancer, Marrow Bone Transplant Center, CEP 21941-590, Rio de Janeiro, RJ, Brazil
,
Dilvani O Santos Federal Fluminense University, Biology Institute, Department of Celular and Molecular Biology, CEP 24020-150 Niterói, Rio de Janeiro, Brazil +55 21 26292294; +55 21 26292284; [email protected]
,
Saulo Bourguinhon Federal Fluminense University, Biology Institute, Department of Celular and Molecular Biology, CEP 24020-150 Niterói, Rio de Janeiro, Brazil +55 21 26292294; +55 21 26292284; [email protected]
,
Lucio M Cabral Federal University of Rio de Janeiro, Faculty of Pharmacy, CEP 21941-590, Rio de Janeiro, RJ, Brazil
,
Carlos R Rodrigues Federal University of Rio de Janeiro, Faculty of Pharmacy, CEP 21941-590, Rio de Janeiro, RJ, Brazil
&
Helena C Castro Federal Fluminense University, Biology Institute, Department of Celular and Molecular Biology, CEP 24020-150 Niterói, Rio de Janeiro, Brazil +55 21 26292294; +55 21 26292284; [email protected]; Federal Fluminense University, Biology Institute, Neuroimmunology Postgraduate course, CEP 24020-150 Niterói, Rio de Janeiro, Brazil
 show all
Pages 1035-1047 | Published online: 12 Jul 2008

Bibliography

  • Szyf M. Targeting DNA methylation in cancer. Ageing Res Rev 2003;2:299-328
  • Gosden, RG, Feinberg AP. Genetics and epigenetics-nature's pen-and-pencil set. N Engl J Med 2007;356:731-3
  • Singal R, Ginder GD. DNA methylation. Blood 1999;93:4059-70
  • Razin A, Riggs AD. DNA methylation and gene function. Science 1980;210:604-10
  • Razin A, Shemer. Epigenetic control of gene expression. Results Probl Cell Differ 1999;25:189-204
  • Gold M, Hurwitz J. The enzymatic methylation of ribonucleic acid and deoxyribonucleic acid. VI. Further studies on the properties of the deoxyribonucleic acid methylation reaction. J Biol Chem 1964;239:3866-74
  • Cheng X, Roberts RJ. AdoMet-dependent methylation, DNA methyltransferases and base flipping. Nucleic Acids Res 2001;29:3784-95
  • Hermann A, Gowher H, Jeltsh A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 2004;61:2571-87
  • Doerfler W, Schubbert R, Heller H, et al. Integration of foreign DNA and its consequences in mammalian systems. Trends Biotechnol 1997;15:297-301
  • Bender J. Chromatin-based silencing mechanisms. Curr Opin Plant Biol 2004;7:521-6
  • Turek-Plewa J, Jagodzinski PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 2005;10:631-47
  • Szyf M. Therapeutic implications of DNA methylation. Future Oncol 2005;1:125-35
  • Feng, YQ, Desprat R, Fu H, et al. DNA methylation supports intrinsic epigenetic memory in mammalian cells. PLoS Genet 2006;2:461-70
  • Turker MS, Bestor TH. Formation of methylation patterns in the mammalian genome. Mutat Res 1997;386:119-30
  • Newell-Price J, Clark AJL, King P. DNA methylation and silencing of gene expression. TEM 2000;11:142-8
  • Siedlecki P, Boy RG, Comagic S, et al. Establishment and functional validation of a structural homology model for human DNA methyltransferase 1. Biochem Biophys Res Commun 2003;306:558-63
  • Lin H, Yamada Y, Nguyen S, et al. Suppression of intestinal neoplasia by deletion of Dnmt3b. Mol Cell Biol 2006;26:2976-83
  • Hermann A, Schmitt S, Jeltsch A. The human Dnmt2 has residual DNA-(cytosine-C5) methyltransferase activity. J Biol Chem 2003;278:31717-21
  • Jeltsch A, Nellen W, Lyko F. Two substrates are better than one: dual specificities for Dnmt2 methyltransferases. Trends Biochem Sci 2006;31:306-8
  • Buryanov Y, Shevchuk T. The use of prokaryotic DNA. methyltransferases as experimental and analytical tools in modern biology. Anal Biochem 2005;338:1-11
  • Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000;9:2395-402
  • Cheng X. Structure and function of DNA methyltransferases. Ann Rev Biophys Biomol Struct 1995;24:293-318
  • O'Gara M, Klimasauskas S, Roberts RJ, et al. Enzymatic C5-cytosine methylation of DNA: mechanistic implications of new crystal structures for HhaI methyltransferase-DNA-AdoHcy complexes. J Mol Biol 1996;261:634-45
  • Reither S, Li F, Gowher H, et al. Catalytic mechanism of DNA-(cytosine-C5)-methyltransferases revisited: covalent intermediate formation is not essential for methyl group transfer by the murine Dnmt3a enzyme. J Mol Biol 2003;329:675-84
  • Bestor TH. Activation of mammalian DNA methyltransferase by cleavage of Zn binding regulatory domain. EMBO J 1992;11:2611-7
  • Liang G, Chan MF, Tomigahara Y, et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol Cell Biol 2002;22:480-91
  • Mertineit C, Yoder JA, Taketo T, et al. Sex-specific exons control DNA methyltransferase in mammalian germ cells. Development 1998;125:889-97
  • Ding F, Chaillet JR. In vivo stabilization of the Dnmt1 (cytosine-5)-methyltransferase protein. Proc Natl Acad Sci USA 2002;99:14861-6
  • Fatemi M, Hermann A, Pradhan S, et al. The activity of the murine DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic domain with the N-terminal part of the enzyme leading to an allosteric activation of the enzyme after binding to methylated DNA. J Mol Biol 2001;309:1189-99
  • Carlson LL, Page AW, Bestor TH. Properties and localization of DNA methyltransferase in preimplantation mouse embryos: implications for genomic imprinting. Genes Dev 1992;6:2536-41
  • Yoder JA, Bestor TH. A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast. Hum Mol Genet 1998;7:279-84
  • Pradhan S, Esteve PO. Mammalian DNA (cytosine-5) methyltransferases and their expression. Clin Immunol 2003;109:6-16
  • Dong A, Yoder JA, Zhang X, et al. Structure of human DNMT2, an enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA. Nucleic Acids Res 2001;29:439-48
  • Van den Wyngaert I, Sprengel J, Kass SU, et al. Cloning and analysis of a novel human putative DNA methyltransferase. FEBS Lett 1998;426:283-9
  • Goll MG, Kirpekar F, Maggert KA, et al. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 2006;311:395-8
  • Chen, T, Ueda Y, Dodge JE, et al. Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse. Mol Cell Biol 2003;23:5594
  • Chen T, Ueda Y, Xie S, et al. A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J Biol Chem 2002;277:38746-54
  • Xie S, Wang Z, Okano M, et al. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene 1999;236:87-95
  • Qiu C, Sawada K, Zhang X, et al. The PWWP domain of mammalian DNA methyltransferase Dnmt3b defines a new family of DNA-binding folds. Nat Struct Biol 2002;9:217-24
  • Aapola U, Kawasaki K, Scott HS, et al. Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics 2000;65:293-8
  • Suetake I, Shinozaki F, Miyagawa J. DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction. J Biol Chem 2004;279:27816-23
  • Szyf M. DNA Methylation and demethylation as targets for anticancer therapy. Biochemistry 2005;70:533-49
  • Feinberg AP. A genetic approach to cancer epigenetics. Cold Spring Harb Symp Quant Biol 2005;70:335-41
  • Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006;7:21-33
  • Issa JP, Baylin SB, Herman JG. DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia 1997;11:7-11
  • Wong IH, Lo YM. New markers for cancer detection. Curr Oncol Rep 2002;4:471-7
  • Siu LL, Chan JK, Wong KF. Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas. Br J Haematol 2003;122:70-7
  • Fenaux P. Inhibitors of DNA methylation: beyond myelodysplastic syndromes. Nat Clin Pract Oncol 2005;2:36-44
  • Schulz WA. DNA methylation in urological malignancies. Int J Oncol 1998;13:151-67
  • Fajkus J, Vyskot B, Bezdek M. Changes in chromatin structure due to hypomethylation induced with 5-azacytidine or DL-ethionine. FEBS Lett 1992;314:13-6
  • Szyf M. DNA methylation properties: consequences for pharmacology. Trends Pharmacol Sci 1994;15:233-8
  • Silverman LR, Mufti GJ. Methylation inhibitor therapy in the treatment of myelodysplastic syndrome. Nat Clin Pract Oncol 2005;2:12-23
  • Christman JK. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 2002;21:5483-95
  • Otterson GA, Khleif SN, Chen W, et al. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16ink4a protein induction by 5-azaC 2′ deoxycytidine. Oncogene 1995;11:1211-6
  • Gore SD. Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies. Nat Clin Pract Oncol 2005;2:30-5
  • Von Hoff DD, Slavik M. 5-azacytidine – a new anticancer drug with significant activity in acute myeloblastic leukemia. Adv Pharmacol Chemother 1977;14:285-326
  • Oka M, Meacham AM, Hamazaki T, et al. De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2′ deoxycytidine. Oncogene 2005;24:3091-9
  • Laird PW, Jackson-Grusby L, Fazeli A, et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995;81:197-205
  • Vogler WR, Miller DS, Keller JW. 5-Azacytidine (NSC 102816): a new drug for the treatment of myeloblastic leukemia. Blood 1976;48:331-7
  • Baylin SB, Fearon ER, Vogelstein B, et al. Hypermethylation of the 5′ region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood 1987;70:412-7
  • Juttermann R, Li E, Jaenisch R. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA 1994;91:11797-801
  • Gaudet F, Hodgson JG, Eden A, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003;300:489-92
  • Kim GD, Ni J, Kelesoglu N, et al. Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J 2002;2:4183-95
  • Beaulieu N, Morin S, Chute IC, et al. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J Biol Chem 2002;277:28176-81
  • Herranz M, Martín-Caballero J, Fraga MF, et al. The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma. Blood 2006;107:1174-7
  • Scott SA, Lakshimikuttysamma A, Sheridan DP, et al. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. Exp Hematol 2007;35:263-73
  • Fang M, Chen D, Yang CS. Dietary polyphenols may affect DNA methylation. J Nutr 2007;137:223-8
  • Pina IC, Gautschi JT, Wang GY, et al. Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase. J Org Chem 2003;68:3866-73
  • Castellano A, Kuck D, Novellino MSE, et al. Constrained analogues of Procaine as novel small molecule inhibitors of DNA methyltransferase-1. J Med Chem 2008;51:2321-5
  • Brueckner B, Garcia Boy R, Siedlecki P, et al. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res 2005;65:6305-11
  • Schirrmacher E, Beck C, Brueckner B, et al. Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases. Bioconjug Chem 2006;17:261-6
  • Oki Y, Issa JP. Review: recent clinical trials in epigenetic therapy. Rev Recent Clin Trials 2006;1:169-82
  • Wijermans PW, Rüter B, Baer MR, et al. Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML). Leuk Res 2008;32:587-91
  • Amato RJ. Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy. Clin Genitourin Cancer 2007;5:422-6
  • Klisovic RB, Stock W, Cataland S, et al. A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia. Clin Cancer Res 2008;14:2444-9
  • Winquist E, Knox J, Ayoub JP. Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: a National Cancer Institute of Canada Clinical Trials Group investigational new drug study. Invest New Drugs 2006;24:159-67
  • Glozak MA, Sengupta N, Zhang X, et al. Acetylation and deacetylation of non-histone proteins. Gene 2005;363:15-23
  • Ouaissi M, Ouaissi A. Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases. J Biomed Biotechnol 2006;13474-84
  • Turlais F, Hardcastle A, Rowlands M, et al. High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate). Anal Biochem 2001;298:62-8
  • Muraoka M, Konishi M, Kikuchi-Yanoshita R, et al. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 1996;12:1565-9
  • Gayther SA, Batley SJ, Linger L, et al. Mutations truncating the EP300 acetylase in human cancers. Nat Genet 2000;24:300-3
  • Gray SG, Eriksson T, Ekstrom TJ. Methylation, gene expression and the chromatin connection in cancer. Int J Mol Med 1999;4:333-50
  • Yoshida M, Kijima M, Akita M, et al. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990;265:17174-9
  • Kijima M, Yoshida M, Sugita K, et al. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J Biol Chem 1993;268:22429-35
  • Nakao Y, Fusetani N. Enzyme inhibitors from marine invertebrates. J Nat Prod 2007;70:689-710
  • Perez-Plasencia C, Duenas-Gonzalez A. Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy? Mol Cancer 2006;5:27
  • Lyon CM, Linge DK, et al. DNA demethylating agents and a PPA-c agonist cooperate to induce apoptosis in lung cancer cell lines. Proc Am Assoc Cancer Res 2006;41-7
  • Candelaria M, Gallardo-Rincón D, Arce C, et al. A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. Ann Oncol 2007;18:1529-38
  • Beltran AS, Sun X, Lizardi PM, et al. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor. Mol Cancer Ther 2008;7:1080-90
  • Issa JP, Garcia-Manero G, Giles FJ, et al. Phase 1 study of low dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies. Blood 2004;103:1635-40
  • Hellebrekers DM, Griffioen AW, van Engeland M. Dual targeting of epigenetic therapy in cancer. Biochim Biophys Acta 2007;1775:76-91
  • Pan MR, Chang HC, Chuang LY, et al. The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells. Exp Biol Med 2008;233:456-62
  • Plimack ER, Stewart DJ, Issa JJ. Combining epigenetic and cytotoxic therapy in the treatment of solid tumors. J Clin Oncol 2007;25:4519-21
  • Issa JJ, Gharibyan V, Cortes J, Jelinek J, et al. Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. J Clin Oncol 2005;23:3948-56
  • Mulero-Navarro S, Esteller M. Epigenetic biomarkers for human cancer: the time is now. Crit Rev Oncol Hematol, published online 21 April 2008, doi:10.1016/j.critrevonc.2008.03.001
  • Agrawal S, Unterberg M, Koschmieder S, et al. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia. Cancer Res 2007;67:1370-7
  • Terra AP, Murta EF, Maluf PJ, et al. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III. Tumori 2007;93:572-9
  • Agrawal S, Unterberg M, Koschmieder S, et al. DNA Methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia. Cancer Res 2007;67:1370-7
  • Lorente A, Mueller W, Urdangarín E, et al. Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR. BMC Cancer 2008;8:61
  • Jeuken JW, Cornelissen SJ, Vriezen M, et al. MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas. Lab Invest 2007;87:1055-65

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.